Post Categories
Consensus Drives Collaboration: In-Depth Cell Analysis Can Accelerate Understanding of the Brain
December 13, 2021
A large team of researchers has made great strides in developing a census and atlas of the cell types found in the mammalian primary…
Chimpanzee DNA Sheds Light on Human Brain Evolution
December 8, 2021
In evolutionary terms, chimpanzees are humans’ closest living relatives. But how close are we, really? Science Daily reports that researchers at Lund University in…
Using Brain Stimulation to “Switch Tracks” in Mental Health Patients’ Train of Thought
December 6, 2021
A proof-of-concept study of brain stimulation among patients with epilepsy may have revealed a revolutionary way to treat people with severe depression, anxiety, addiction…
How Congress Could Regulate Medicare Drug Prices
December 1, 2021
Prescription drug costs continue to be a concern for many Americans. But now, as Congress works to finalize President Biden’s Build Back Better social…
When NSAAs Enter the Mix, Protein Therapeutics May Thrive
November 15, 2021
Protein therapeutics may soon represent a $200 billion market despite a few inherent limitations. The processes for manufacturing therapeutic proteins are not very efficient…
Can Gene Therapy Cure Sickle Cell Disease?
November 8, 2021
Despite being one of the world’s most common inherited blood disorders, sickle cell disease has few treatment options, even with the approval of three…
The Flu Shot and COVID: Will the Delta Variant Play a Role?
November 3, 2021
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent…
New Hope for Ultra-Rare Childhood Disease
November 1, 2021
The recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease,…
CRISPR and the Continuing Quest for CAR-T Safety and Durability
October 27, 2021
CAR-T is an immunotherapy that is currently used to treat blood cancers and is in clinical trials to treat other cancers as well. This…
mRNA: Great Expectations vs. Limited Applications
October 18, 2021
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…
Will You Need a COVID-19 Vaccine Booster Shot?
October 13, 2021
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
October 11, 2021
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…
“It’s Incredible” — Breakthrough Spinal Implant Restores Walking Ability Lost Due to Parkinson’s Disease
February 12, 2024
Marc, a 63-year-old from Bordeaux, France, has lived with Parkinson’s disease for more than two decades. The disease had increasingly hindered his mobility, causing…
“Like Day and Night” — CRISPR’s Life-Changing Potential in Sickle Cell Disease
February 5, 2024
A groundbreaking gene editing therapy for sickle cell disease from CRISPR Therapeutics and Vertex Pharmaceuticals has received approval from the U.S. Food and Drug…
Pharma’s Expanding Arsenal Against Mosquitoes — the World’s Deadliest Creatures
January 29, 2024
Although mosquitoes measure less than an inch and weigh a mere 2.5 milligrams, the disease burdens they carry make them the “deadliest animal on…
Scientists Raise the Alarm Over H1N2 Swine Flu
January 24, 2024
Late last year, medical professionals in the United Kingdom made an alarming discovery: An unusual type of H1N2 swine flu had been detected in…
The Psychedelic Renaissance and the Mysteries of Mind-Altering Medicine
January 22, 2024
Psychiatric treatment is undergoing a profound shift as once-stigmatized psychedelic drugs gain mainstream acceptance. For instance, the Food and Drug Administration (FDA) approved a…
It’s Going Around — Biotechs Bet on Circular RNA’s Therapeutic Potential
January 15, 2024
RNA-based vaccines have achieved superstar status and Nobel Prize recognition. Now, several biotechnology firms are considering circular RNAs (circRNAs) as a platform for therapeutic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…